Timsit, Jean-François http://orcid.org/0000-0002-6063-7383
Bassetti, Matteo
Cremer, Olaf
Daikos, George
de Waele, Jan
Kallil, Andre
Kipnis, Eric
Kollef, Marin
Laupland, Kevin
Paiva, Jose-Artur
Rodríguez-Baño, Jesús
Ruppé, Étienne
Salluh, Jorge
Taccone, Fabio Silvio
Weiss, Emmanuel
Barbier, François
Article History
Received: 14 November 2018
Accepted: 4 January 2019
First Online: 18 January 2019
Compliance with ethical standards
:
: Dr. Kollef’s effort was supported by the Barnes-Jewish Hospital Foundation. Dr. Barbier received consulting fees, speaker fees, and conference invitation from MSD, and conference invitation from Pfizer. Dr. De Waele has been consultant for Accelerate Diagnostics, Bayer Healthcare, Grifols, MSD, and Pfizer (all honoraria paid to institution). Dr. Timsit received fees for scientific advisory boards from Pfizer, Bayer pharma, Merck, Nabriva and received fees for lectures from Biomerieux, Pfizer, Merck, Gilead. Dr. Rodríguez-Baño received honoraria for accredited educational activities from Merck and for coordination of a non-product-related research project by Astra-Zeneca. Dr. Ruppé received speaker fees from MSD, Sanofi, and Mobidiag, fees for scientific advisory board from Pathoquest and MaaT Pharma, and consulting fees from DaVolterra. Dr. Daikos reports grants from Pfizer, Gilead, and honoraria from Pfizer, Achaogen, MSD, and Rempex, outside of this work. Dr. Kipnis received fees for scientific advisory boards, lectures, and conference invitation from MSD, for lectures and conference invitations from Pfizer and Fresenius, and conference invitations from LFB and Gilead. Dr. Weiss reports speaker fees form Baxter, MSD, and Gilead, congress and travel reimbursements from MSD and Eumedica, and having participated in an advisory board from Biomerieux.
Free to read: This content has been made available to all.